ARTICLE | Company News
Amrad, Merck deal
June 30, 2003 7:00 AM UTC
AML and MRK’s Merck Sharp & Dohme Pty. Ltd. subsidiary (Sydney, Australia) partnered to develop drugs for respiratory disease, including asthma, and cancer. Merck will receive an exclusive license to ...